Stephen C. Pak

9.1k total citations
53 papers, 1.9k citations indexed

About

Stephen C. Pak is a scholar working on Molecular Biology, Aging and Cancer Research. According to data from OpenAlex, Stephen C. Pak has authored 53 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 23 papers in Aging and 15 papers in Cancer Research. Recurrent topics in Stephen C. Pak's work include Genetics, Aging, and Longevity in Model Organisms (23 papers), Protease and Inhibitor Mechanisms (15 papers) and Cellular transport and secretion (7 papers). Stephen C. Pak is often cited by papers focused on Genetics, Aging, and Longevity in Model Organisms (23 papers), Protease and Inhibitor Mechanisms (15 papers) and Cellular transport and secretion (7 papers). Stephen C. Pak collaborates with scholars based in United States, Australia and France. Stephen C. Pak's co-authors include Gary A. Silverman, Cliff J. Luke, David H. Perlmutter, Linda P. O’Reilly, James C. Whisstock, David J. Askew, Phillip I. Bird, Olivia S. Long, David H. Perlmutter and Sule Çataltepe and has published in prestigious journals such as Cell, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Stephen C. Pak

52 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen C. Pak United States	25	846	427	412	291	228	53	1.9k
M. Inmaculada Barrasa United States	27	2.5k 2.9×	379 0.9×	352 0.9×	130 0.4×	461 2.0×	45	3.7k
Nathan D. Trinklein United States	23	2.0k 2.4×	330 0.8×	91 0.2×	214 0.7×	126 0.6×	39	2.6k
Yuwen Chen China	19	3.8k 4.5×	748 1.8×	214 0.5×	239 0.8×	261 1.1×	78	4.6k
Philip R. Gafken United States	29	2.7k 3.2×	236 0.6×	71 0.2×	155 0.5×	201 0.9×	50	3.4k
Baktiar Karim United States	25	1.7k 2.0×	614 1.4×	141 0.3×	101 0.3×	159 0.7×	59	2.8k
Jianping Zhang China	28	3.0k 3.5×	437 1.0×	89 0.2×	312 1.1×	244 1.1×	63	3.7k
Peter Newham United Kingdom	23	1.2k 1.4×	456 1.1×	51 0.1×	214 0.7×	96 0.4×	38	2.6k
Keith P. Ray United Kingdom	22	756 0.9×	334 0.8×	197 0.5×	78 0.3×	132 0.6×	53	2.3k
Kaoru Tominaga Japan	24	2.6k 3.1×	338 0.8×	93 0.2×	293 1.0×	299 1.3×	74	3.5k
Vic E. Myer United States	17	2.7k 3.2×	505 1.2×	77 0.2×	297 1.0×	284 1.2×	22	3.3k

Countries citing papers authored by Stephen C. Pak

Since Specialization

Citations

This map shows the geographic impact of Stephen C. Pak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen C. Pak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen C. Pak more than expected).

Fields of papers citing papers by Stephen C. Pak

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen C. Pak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen C. Pak. The network helps show where Stephen C. Pak may publish in the future.

Co-authorship network of co-authors of Stephen C. Pak

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen C. Pak. A scholar is included among the top collaborators of Stephen C. Pak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen C. Pak. Stephen C. Pak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Seong Won, Young Mi Oh, Matheus B. Victor, et al.. (2023). Longitudinal modeling of human neuronal aging reveals the contribution of the RCAN1–TFEB pathway to Huntington’s disease neurodegeneration. Nature Aging. 4(1). 95–109. 10 indexed citations

Wang, Songyan, Cliff J. Luke, Stephen C. Pak, et al.. (2022). SERPINB3 (SCCA1) inhibits cathepsin L and lysoptosis, protecting cervical cancer cells from chemoradiation. Communications Biology. 5(1). 46–46. 18 indexed citations

Baldridge, Dustin, Michael F. Wangler, Shinya Yamamoto, et al.. (2021). Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: current state and a future vision. Orphanet Journal of Rare Diseases. 16(1). 206–206. 49 indexed citations

Moreno-Ibarra, Marco, Huiyan Huang, Hyori Kim, et al.. (2019). CemOrange2 fusions facilitate multifluorophore subcellular imaging in C. elegans. PLoS ONE. 14(3). e0214257–e0214257. 12 indexed citations

Wang, Yan, Murat Can Çobanoğlu, Jie Li, et al.. (2019). An analog of glibenclamide selectively enhances autophagic degradation of misfolded α1-antitrypsin Z. PLoS ONE. 14(1). e0209748–e0209748. 15 indexed citations

Markovina, Stephanie, Songyan Wang, Lauren E. Henke, et al.. (2017). Serum squamous cell carcinoma antigen as an early indicator of response during therapy of cervical cancer. British Journal of Cancer. 118(1). 72–78. 55 indexed citations

O’Reilly, Linda P., et al.. (2016). High-Throughput, Liquid-Based Genome-Wide RNAi Screening in C. elegans. Methods in molecular biology. 1470. 151–162. 5 indexed citations

Cummings, Erin E., Linda P. O’Reilly, Mark T. Miedel, et al.. (2015). The Aggregation-Prone Intracellular Serpin SRP-2 Fails to Transit the ER inCaenorhabditis elegans. Genetics. 200(1). 207–219. 1 indexed citations

Cummings, Erin E., et al.. (2014). A high-content assay for identifying small molecules that reprogram C. elegans germ cell fate. Methods. 68(3). 529–535. 12 indexed citations

10.

Long, Olivia S., Joon Hyeok Kwak, Cliff J. Luke, et al.. (2014). A C. elegans model of human α1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover. Human Molecular Genetics. 23(19). 5109–5122. 24 indexed citations

11.

O’Reilly, Linda P., Cliff J. Luke, David H. Perlmutter, Gary A. Silverman, & Stephen C. Pak. (2013). C. elegans in high-throughput drug discovery. Advanced Drug Delivery Reviews. 69-70. 247–253. 192 indexed citations

12.

O’Reilly, Linda P., David H. Perlmutter, Gary A. Silverman, & Stephen C. Pak. (2013). α1-Antitrypsin deficiency and the hepatocytes – An elegans solution to drug discovery. The International Journal of Biochemistry & Cell Biology. 47. 109–112. 4 indexed citations

13.

Silverman, Gary A., James C. Whisstock, Stephen Bottomley, et al.. (2010). Serpins Flex Their Muscle. Journal of Biological Chemistry. 285(32). 24299–24305. 126 indexed citations

14.

Whisstock, James C., Gary A. Silverman, Phillip I. Bird, et al.. (2010). Serpins Flex Their Muscle. Journal of Biological Chemistry. 285(32). 24307–24312. 92 indexed citations

15.

Askew, David J., Sule Çataltepe, Vasantha Kumar, et al.. (2007). SERPINB11 Is a New Noninhibitory Intracellular Serpin. Journal of Biological Chemistry. 282(34). 24948–24960. 27 indexed citations

16.

Silverman, Gary A., James C. Whisstock, David J. Askew, et al.. (2004). Human clade B serpins (ov-serpins) belong to a cohort of evolutionarily dispersed intracellular proteinase inhibitor clades that protect cells from promiscuous proteolysis. Cellular and Molecular Life Sciences. 61(3). 301–325. 150 indexed citations

17.

Pak, Stephen C., Vasantha Kumar, Christopher Tsu, et al.. (2004). SRP-2 Is a Cross-class Inhibitor That Participates in Postembryonic Development of the Nematode Caenorhabditis elegans. Journal of Biological Chemistry. 279(15). 15448–15459. 35 indexed citations

18.

Jayakumar, Arumugam, Ya’an Kang, Mitchell J. Frederick, et al.. (2002). Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis. Archives of Biochemistry and Biophysics. 409(2). 367–374. 47 indexed citations

19.

Askew, Yuko S., Stephen C. Pak, Cliff J. Luke, et al.. (2001). SERPINB12 Is a Novel Member of the Human ov-serpin Family That Is Widely Expressed and Inhibits Trypsin-like Serine Proteinases. Journal of Biological Chemistry. 276(52). 49320–49330. 43 indexed citations

20.

Uemura, Yoshiki, Stephen C. Pak, Cliff J. Luke, et al.. (2000). Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. International Journal of Cancer. 89(4). 368–377. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact